StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report released on Thursday. The firm issued a hold rating on the stock.
Brooklyn ImmunoTherapeutics Trading Down 7.2 %
NYSE BTX opened at $0.30 on Thursday. The company has a 50-day moving average price of $0.49 and a two-hundred day moving average price of $1.16. The stock has a market cap of $17.65 million, a price-to-earnings ratio of -0.13 and a beta of 4.61. Brooklyn ImmunoTherapeutics has a 52 week low of $0.17 and a 52 week high of $10.10.
About Brooklyn ImmunoTherapeutics
Further Reading
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- Consumer Staples Stocks, Explained
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Breakout Stocks: What They Are and How to Identify Them
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- What is a SEC Filing?
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.